RecioMed Clinical Research Network

09/07/2024

“If someone wishes for good health, one must first ask oneself if he is ready to do away with the reasons for his illness. Only then is it possible to help him.”
Hippocrates

03/02/2024

In an amazing event with .

02/07/2024

👨🏻‍⚕️🩻🩺🥼Without study volunteers there can be no medical advancements. We understand that many new patients may feel uncertain about participating in a clinical trial so Clinical Research is committed to providing the necessary attention and safety oversight that patients need to begin their medical research journey.

Everything we do puts our patients first. We are a patient-centric clinical research company and you are at the focus of all of our efforts.

02/05/2024

🩺
Researchers at Memorial Sloan Kettering Cancer Center have developed an off-the-shelf cancer vaccine, ELI-002 2P, showing promising early results for treating pancreatic and colorectal cancers with specific KRAS mutations. This vaccine is designed to be readily available, cost-effective, and faster to administer, making it a potential breakthrough for patients with limited treatment options. The Phase I trial involved 25 patients, demonstrating the vaccine's safety, immune system stimulation, and positive impact on relapse-free survival, particularly in those with a higher T-cell response. These findings offer hope for more effective treatments for pancreatic and colorectal cancer patients.

A new cancer vaccine targeting KRAS shows encouraging early results as an off-the-shelf treatment for patients with pancreatic or colorectal cancer,

01/15/2024

Interested in participating in our ? Here is how: reciomed.com/active-studies…
Make an appointment or give us a call. We might be able to help you with your medical condition. We will provide you with all the information and informed consent. Become a part of medical innovation!

01/09/2024

¿Por qué participar en ensayos clínicos?

✨ Acceso a Tratamientos de Vanguardia: Al unirte a nuestros ensayos clínicos, obtienes acceso exclusivo a los tratamientos y terapias más recientes que podrían revolucionar la atención médica. ¡Sé pionero en la innovación médica!

✨ Genera un Impacto Significativo: Tu participación no se trata solo de beneficios personales; se trata de contribuir al bien común. Cada ensayo nos acerca un paso más a descubrimientos que pueden cambiar la vida y ayudar a innumerables personas.

✨ Recibe Atención de Expertos: Nuestro dedicado equipo de expertos está comprometido con tu bienestar durante todo el proceso del ensayo. Recibirás atención personalizada, asegurando una experiencia segura y positiva.

Cómo Puedes Contribuir:

🔬 Avanzando en la Investigación: Tu participación acelera el ritmo de la investigación médica. Cada ensayo nos brinda información valiosa que da forma al futuro de la atención médica para las generaciones futuras.

🔬 Mejorando las Opciones de Tratamiento: Al participar, contribuyes activamente al desarrollo de opciones de tratamiento nuevas y mejoradas. Tu viaje podría conducir a descubrimientos que cambien la vida de personas en todo el mundo.

🔬 Abriendo Camino para Otros: Tu valentía y compromiso inspiran a otros a unirse a la causa. Juntos, creamos una comunidad dedicada a ampliar los límites de lo posible en la medicina.

🔑 Cómo Participar:
1️⃣ Llámanos o envíanos un correo electrónico al 1(561) 614-0959 / trials@reciomed.com
2️⃣ Completa el formulario de aplicación rápida para expresar tu interés en https://reciomed.com/active-studies/
3️⃣ Nuestro equipo dedicado se pondrá en contacto para guiarte en los próximos pasos y responder cualquier pregunta que puedas tener.

01/03/2024

Scientists have discovered a new type of called zosurabalpin that effectively fights against dangerous, drug-resistant bacteria, particularly Carbapenem-resistant Acinetobacter baumannii (CRAB). This breakthrough is crucial as existing antibiotics struggle against these microbes. Zosurabalpin works by inhibiting a complex of proteins, trapping lipopolysaccharide (LPS) during its transport to the outer membrane of Gram-negative bacteria, ultimately causing their death. Unlike traditional antibiotics, zosurabalpin shows promise in clinical trials and targets a specific bacterium, reducing potential harm to normal gut microbes. This discovery offers hope for addressing the urgent threat of antimicrobial resistance, especially in cases where current treatments are failing.

Read the article:

A new class of antibiotics has been discovered that is effective against multidrug-resistant bacteria, offering new opportunities to tackle these dangerous microbes.

01/03/2024

Why Participate in Clinical Trials?

✨ Access to Cutting-Edge Treatments: By joining our clinical trials, you get exclusive access to the latest treatments and therapies that could revolutionize healthcare. Be at the forefront of medical innovation!

✨ Make a Meaningful Impact: Your participation is not just about personal benefits; it’s about contributing to the greater good. Every trial brings us one step closer to life-changing discoveries that can help countless others.

✨ Receive Expert Care: Our dedicated team of experts is committed to your well-being throughout the entire trial process. You’ll receive personalized care and attention, ensuring a safe and positive experience.

How You Can Contribute:

🔬 Advancing Research: Your involvement accelerates the pace of medical research. Each trial brings us valuable insights and data that shape the future of healthcare for generations to come.

🔬 Improving Treatment Options: By participating, you actively contribute to the development of new and improved treatment options. Your journey could lead to breakthroughs that change the lives of people around the world.

🔬 Paving the Way for Others: Your bravery and commitment inspire others to join the cause. Together, we create a community dedicated to pushing the boundaries of what’s possible in medicine.

🔑 How to Participate:
1️⃣ Call or email us 1(561) 614-0959 / trials@reciomed.com
2️⃣ Fill out the quick application form to express your interest at https://reciomed.com/active-studies/
3️⃣ Our dedicated team will reach out to guide you through the next steps and answer any questions you may have.

12/31/2023

🎉 Wishing you a Happy New Year 2024 filled with joy, success, and new beginnings! 🌟 ¡Feliz Año Nuevo 2024 lleno de alegría, éxito y nuevos comienzos! 🥳 #2024

12/29/2023

Researchers have discovered a groundbreaking approach to eliminate cancer cells using molecular jackhammers. These tiny entities, termed molecular jackhammers, operate through a unique mechanism called vibronic-driven action (VDA). By activating specific vibrations in cell-membrane-associated molecules with near-infrared light, VDA induces rapid cell death without reliance on reactive oxygen species or causing thermal damage. This method successfully eradicated human melanoma cells in vitro with minimal concentrations of aminocyanines and low doses of light. In mouse models, a 50% tumor-free rate for melanoma was achieved. Given the resistance-proof nature of this mechanical force, molecular jackhammers offer a promising alternative for cancer cell death induction.

In contrast to photothermal therapy requiring high powers over extended times and photodynamic therapy being abrogated by inhibitors of reactive oxygen species, actuation of vibronic modes in single molecules—molecular jackhammers—can now induce efficient cancer cell death. Here, the mechanical ...

12/29/2023

Hello!! 👋👋
Physicians, consider integrating clinical research into your practice for both patient benefits and practice enhancement. Despite having access to eligible patients, many physicians are hindered by time constraints and a lack of understanding of the clinical research landscape. This non-participation contributes to delays in clinical trials and escalated pharmaceutical costs. The perception problem of clinical research being confined to obscure settings needs correction. In reality, physicians can seamlessly conduct studies within their private practices, leading to additional revenue streams and staying abreast of cutting-edge treatments. Overcoming the dual challenges of awareness and unfounded fears, such as potential FDA fines, is crucial.

Get involved! Contact us:
📞 1-561-614-0959

https://www.reciomed.com/physicians/

Why physicians need to consider clinical research as a viable option for their patients as well as for their private practices.

12/24/2023

Wishing you all a festive season filled with love, joy, and endless laughter! May your Christmas be merry and bright. Cheers to making cherished memories with family and friends! 🎅🏻🎁

🎄 ¡Les deseamos a todos una temporada festiva llena de amor, alegría y risas interminables! Que su Navidad sea alegre y brillante. ¡Brindemos por crear recuerdos inolvidables con familia y amigos! 🎅🏻🎁